On Demand Virtual R&D Event Replay:
“Rectifying Protein Dysfunction: RTY-694 for the Treatment of Primary Sclerosing Cholangitis”
Bharat Reddy, Ph.D.

Bharat Reddy, Ph.D.

Chief Business Officer

Bharat Reddy, Ph.D., is the Chief Business Officer at Rectify Pharma. Prior to joining Rectify, Bharat served as Vice President, Strategy and Business Development, at Kelonia Therapeutics where he oversaw the negotiation of a multi-year collaboration and licensing agreement with Astellas Pharmaceuticals. Bharat has over ten years of experience in business development and corporate strategy in the biotech industry. Previously held positions include Head of Business Development at Catamaran Bio, entrepreneur in residence at SV Health Investors, and Director, Business Development, at bluebird bio. While at SV Health Investors, he played a key role in launching Catamaran Bio. He received his B.A. in Biology and Anthropology from Bowdoin College and his Ph.D. from the Department of Biological Sciences at Columbia University.

Scroll to Top